NEW YORK — The Second Circuit reversed a ruling that had blocked the enforcement of part of New York’s Opioid Stewardship Act, which requires opioid manufacturers and distributors to collectively pay $100 million annually to support statewide programs that provide opioid treatment, recovery, prevention and education services.
The court ruled that the primary purpose of the payment is not to punish or regulate the drug companies but to “raise revenue,” which makes it a tax, depriving the lower court of subject matter jurisdiction.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.